Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-Olds

México Noticias Noticias

Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-Olds
México Últimas Noticias,México Titulares
  • 📰 HuffPostParents
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 53%

At the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.

Pfizer and Moderna are expanding the size of their vaccine trials for children 5 to 11 years old, seeking to better detect very rare heart issues among those vaccinated.

The major vaccine makers are increasing the number of children enrolled in their studies at the prompting of the federal Food and Drug Administration, firstThe FDA asked the companies to include 3,000 children — or double the previous number of participants — in order to be adequately able to detect side effects such as myocarditis or pericarditis, inflammations of the heart, according to unnamed sources who spoke to the Times.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

HuffPostParents /  🏆 414. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

WSJ News Exclusive | Covid-19 Immunity Wanes, but Third Shot Still Rarely Needed, BioNTech CEO SaysWSJ News Exclusive | Covid-19 Immunity Wanes, but Third Shot Still Rarely Needed, BioNTech CEO SaysCovid-19 immunity wanes in people fully vaccinated with the Pfizer-BioNTech shot, but most still won’t need a third dose, the CEO of BioNTech said
Leer más »

Covid-19 Vaccine Pioneer BioNTech Plans to Make New Malaria and Tuberculosis Shots in AfricaCovid-19 Vaccine Pioneer BioNTech Plans to Make New Malaria and Tuberculosis Shots in AfricaBioNTech said it would invest some of the profits from the Covid-19 vaccine it markets with Pfizer into developing shots for malaria and tuberculosis in Africa, part of the company’s plan to establish a production hub for innovative medicines
Leer más »

FDA Grants Priority Review Status to Pfizer VaccineFDA Grants Priority Review Status to Pfizer VaccineThe U.S. Food and Drug Administration has granted priority review status to the Pfizer/BioNTech coronavirus vaccine for people 16 and up.
Leer más »

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyMixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyA mixed vaccination of first AstraZeneca (AZN.L) and then a Pfizer (PFE.N) COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.
Leer más »

‘My Miscarriage Was Appropriated By The COVID Anti-Vaccine Movement’‘My Miscarriage Was Appropriated By The COVID Anti-Vaccine Movement’A look inside the manipulative world of social media’s false COVID vaccine narratives.
Leer más »



Render Time: 2025-04-01 19:10:39